Sign inGet started

Latkin Jed

Insider CIK 1554593 · NAVB Interim COO, Director · PRPH Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PRPH ProPhase Labs, Inc. A Award deriv2024-01-012024-03-19500,000— $0500,000SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award deriv2021-02-152021-02-17100,000— $0100,000SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award deriv2020-08-142020-08-18100,000— $0100,000SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2020-08-142020-08-1850,000— $0107,997SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2020-06-022020-06-0433,997$2.62 $89.1K57,997SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2020-02-202020-02-205,000$1.08 $5.4K17,950SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award deriv2020-02-062020-02-07100,000— $0203,250SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2019-06-052019-06-071,000$1.26 $1.3K12,950SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2019-05-172019-05-171,000$1.46 $1.5K11,950SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2019-05-162019-05-171,500$1.45 $2.2K10,950SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2019-05-152019-05-151,000$1.45 $1.4K9,450SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2019-05-142019-05-152,000$1.84 $3.7K8,450SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2019-05-132019-05-152,400$1.91 $4.6K6,450SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award deriv2019-02-072019-02-111,000,000— $02,065,000SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2017-05-302017-05-317,600$0.44 $3.3K50,159SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2017-05-222017-05-2311,200$0.45 $5.0K42,559SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS P Buy2017-05-192017-05-2314,159$0.45 $6.4K31,359SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2017-05-182017-05-193,900$0.45 $1.8K17,200SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award2017-05-172017-05-1913,300$0.47 $6.3K13,300SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award deriv2017-05-042017-05-051,000,000— $01,065,000SEC↗
NAVB NAVIDEA BIOPHARMACEUTICALS A Award deriv2016-10-142016-11-0120,000— $020,000SEC↗